Goldman Sachs

ATTO: Goldman Sachs Buys $8.5M, Part of Cluster Buy

by
Illustration of SEC Form 4 insider trading disclosure for Attovia Therapeutics stock purchase

Goldman Sachs Group Inc. disclosed the purchase of 500,000 shares of Attovia Therapeutics, Inc. (ATTO) on the open market on August 6, 2026, according to a Form 4 filed with the SEC. The shares were bought at $17.00 apiece for a total outlay of $8,500,000. Following the transaction, Goldman Sachs holds 3,020,632 shares indirectly, through … Read more

Biggest 13F Position Increases for Q1 2026 Ending 2026-03-31

by
Ranked list graphic of the largest institutional 13F position increases for the quarter ending 2026-03-31

Yes, 13F filings are public — every quarter, institutional investment managers with over $100 million in assets are required to disclose their U.S. equity holdings to the SEC, and those filings become a goldmine for anyone curious about where the smart money is moving. Below is a ranked look at the largest dollar-value position increases … Read more